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Copy number alterations (CNAs) can be observed in most of cancer patients. Several oncogenes and tumor
suppressor genes with CNAs have been identified in different kinds of tumor. However, the systematic survey of
CNA-affected functions is still lack. By employing systems biology approaches, instead of examining individual
genes, we directly identified the functional hotspots on human genome. A total of 838 hotspots on human
genome with 540 enriched Gene Ontology functions were identified. Seventy-six aCGH array data of hepatocellular
carcinoma (HCC) tumors were employed in this study. A total of 150 regions which putatively affected by CNAs and
the encoded functions were identified. Our results indicate that two immune related hotspots had copy number
alterations in most of patients. In addition, our data implied that these immune-related regions might be involved
in HCC oncogenesis. Also, we identified 39 hotspots of which copy number status were associated with patient
survival. Our data implied that copy number alterations of the regions may contribute in the dysregulation of the
encoded functions. These results further demonstrated that our method enables researchers to survey biological
functions of CNAs and to construct regulation hypothesis at pathway and functional levels.
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Chromosomal instability is one of the characteristics in
cancer [1] and results in the numerical and structural
alterations of DNA copy number variations (CNAs).
Recently, some literatures have reported the association
of CNAs and patient survival in different tumors [2-4].
Several important oncogenes or tumor suppressors were
also showed with high frequency of gain or loss status in
different cancers. For example, the copy number amplifi-
cation of gene Her2, which is the addicted oncogene in
the HER2+ subtype of breast cancer, was highly correlated
with the gene overexpression [5]. However, in addition to
focal amplification, most tumors display multiple and
broad ranges of copy number change, where large number
of genes are involved in and potentially to be induced or
suppressed due to copy number amplifications or
deletions. Some in vitro studies were performed to survey
the affected functions of CNAs [6-8]. For example,* Correspondence: cheny8@uthscsa.edu
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in any medium, provided the original work is pNicole et al. utilized the shRNA library to identify the GO
and STOP genes which positively and negatively regulate
proliferation to evaluate the effect of gene deletions [7],
respectively. They also proposed a model called ‘Cancer
Gene Island’, which encompasses high density of genes
with the same function within a genomic region [7]. How-
ever, the in vitro studies were labor intensive if not cost
prohibitive. Moreover, it is hard to perform a systematic
analysis based on these approaches, thus, leaving the gene
island model and their functions unexplored.
In conventional gene expression data analysis, several
bioinformatics methods based on the concept of ‘gene
set enrichment analysis’ (GSEA) have been successfully
utilized to explore the underlying molecular pathways
and Gene Ontology functions [9-12]. The GSEA method
assesses the number of overlap genes between two gene
sets: the differentially expressed genes of a certain func-
tional annotation and genes from the entire genome
with the same annotation, to estimate the probability of
the overlapping through the statistical test. The proced-
ure provides a high throughput and systematic analysis
to explore the putative activated pathways or functions.open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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nant cancers and the third leading cause of cancer death
worldwide [13]. Major etiologies associated with HCC are
hepatitis B virus (HBV) and hepatitis C virus (HCV) infec-
tion [14]. Previous studies have been reported in which
comparative genomic hybridization by microarray (aCGH)
was utilized to examine CNAs in HCC. Several regions
with frequent copy number gain and loss were identified.
The CNA-associated oncogenes and tumor suppressors,
such as MYC, JAG1, TP53, and RB1, were also found
[15-18]. The association between survival and CNAs has
been investigated, and ten associated genes were reported
[19]. However, the biological functions altered by CNAs
remain unknown and thus need to be dissected.
According to the concept of Cancer Gene Island, here,
we propose an algorithm to identify the spatial functional
hotspots (SFHs) in human genome based on the enrich-
ment analysis. The human genome is divided firstly into
segments along the genomic sequence coordinate. Then,
the tests of enrichment between the segments and whole
genome functional categories are performed. Finally, a
method which identifies the optimal regions of enriched
functions between the segments was applied to examine
putative SFHs. To demonstrate the ability of our method,
we applied the method to an aCGH data set of HCC. The
result showed several immune-related SFHs which showed
gain and loss in HCC samples. Also, survival-associated
SFHs were identified. The result also indicated that our
system could serve as a useful method to understand the
CNAs-affected functions.
Methods
To identify the SFHs in human genome, we proposed a
novel enrichment analysis that compares the genes con-
tained within a genomic segment with all genes belonging to
the same function categories associated to the genes within
the segment under consideration based on the concept of
gene set enrichment. As shown in Figure 1A, two matrixes,
B and P, were constructed first. The indicator matrix B
contains information whether or not a gene belongs to a
genomic region (spatial segment) determined by a sliding
window along the genomic position of all chromosomes or
B = (bk,i) KxM, where M is the number of genes and K is the
number of genome segments pre-determined and where
bk,i = 1 when ith gene is in the kth segment, otherwise 0.
The matrix P = {pi,l}MxL is also an indicator matrix of
functional gene sets, where L is the number of functional
gene sets and pi,l = 1 when ith gene is in the lth GO (Gene
Ontology) function, otherwise 0. The enrichment is de-
fined as scoring function C of the two matrixes B and P.
ES ¼ C B;Pð Þ ð1ÞHere, we use Fisher's exact test as the score function C
(B, P) (Figure 1B). Let xk ¼
XM
i¼1
bk;i is the number of
genes in the kth segment, yl ¼
XM
i¼1
pi;l is the number of
total genes in gene set l, and zk;l ¼
XM
i¼1
bk;ipi;l is the
number of overlapped genes between the kth segment
and gene set l. The p value of Fisher's exact test between
the genome segment and the gene set can be calculated
by
P x > zk;l
  ¼ X∞
h¼zk;l
xk
h
 
M−xk
yl−h
 
M
yl
  ð2Þ
Based on the p values, we can determine if the func-
tion l was enriched at the genome segment k. Then, we
merge and extend the enriched segments to a merged
window to include all genes involved in the function l if
the segments were located nearby and have position over-
lapping. As shown in Figure 1C, assuming qth to (q + R)th
segments have enrichment for the function l, the genes
involved in the merged windows can be expressed as
vector d:
di ¼ 1; if si > 10; else ;

ð3Þ
where si ¼
XqþRð Þ
t¼q
bt;i . Assuming there are G genes (from
eth to (e + G)th) located in the qth to (q + R)th
enriched window, we defined the subsets of the G genes
which exclude out genes gradually from left or right
side according to the genome coordinate. Two parame-
ters, pL and pR, which perform enrichment analysis
(Fisher's exact test) between the subsets with the gene
set of function l were introduced (Figure 1C). pL and
pR are defined as:
pRg ¼ C deþg ;…; d eþGð Þ
 
;pl
  ð4Þ
pLg ¼ C de;…; deþg
 
; pl
 
; ð5Þ
where g = 1,…,G and C(.) is the enriched score func-
tion. Then, the optimal enriched region o of function l
can be defined as:
o ¼ argmin pRð Þ;…; argmin pLð Þf g: ð6Þ
If the p value of the region o passed the selection
threshold, o was defined as the SFHs of function l.
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Figure 1 Schematic diagram illustrating the enrichment analysis of spatial functional hotspots in human genome. (A) The indicator
matrix B was generated by sliding the detection window along the genome. It contains the information of genes located in each segment. The
matrix P records the gene sets of Gene Ontology. (B) By comparing the two matrices assessed with Fisher's exact test, the p values of gene sets
in each segment were generated. The enriched functions of each segment were then identified if passed the selection criteria. (C) The nearby
segments with the same enriched function were merged to a detection window. The enrichment analysis between the function and the subset
of genes in the windows were performed. The subset was constructed by excluding gene by gene along the left side or right side of the
genome coordinate. The position with the smallest p value of left side and right side excluding subset was defined as the boundaries of the
optimal region of the functional hotspot.
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Figure 2 The summary of the spatial functional hotspots. (A) The histogram of the length of the SFHs. (B) The histogram of the gene
numbers in the SFHs. (C) The SFH number in each chromosome. (D) The SFH density (numbers of SFHs per million base pair) in each
chromosome. (E) The most significant p value and (F) the number of SFHs in the position of human genome. In (E) and (F), the chromosomes
were separated by red broken lines.
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To define the genome segments, the detection window size
was set as one million base pairs (Mbp) after the testing of
three different conditions (Additional file 1: Figure S1).
The sliding distance was set at 0.25 Mbp. The genomic
position of each gene was obtained from Ensembl (version
Homo Sapiens 65) [20], or equivalent to NCBI human gen-
ome GRCh37. Therefore, a total of 12,098 segments were
defined. To construct the functional gene sets, we down-
loaded all records of Gene Ontology from the BioMart
website of Ensembl 65 (http://useast.ensembl.org/info/
data/biomart.html) [20]. A total of 7,654 GO terms were
downloaded. After excluding the gene sets containing
fewer than 15 genes, 1,091, 404, and 275 gene sets associ-
ated to biological process (BP), molecular function (MF),
and cellular component (CC) terms were utilized in this
study, respectively.
aCGH arrays of hepatocellular carcinoma
To identify the functional effect of CNAs in HCC, the
aCGH array data set, GSE14322, was downloaded from
GEO/NCBI website. The data set contains 76 HCC sam-
ples. The determination of CNAs was through the
NEXUS software (BioDiscovery, San Diego, CA, USA).
The CBS segmentation algorithm was performed to
identify the segments of CNAs [21] using the thresholds
of log2 values of fold change larger or smaller than ±0.2.0 5 10 15 20
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figure. The function of ‘intermediate filament’ was enriched at both chrom
chromosomes 7 and 14.Results
Identification of spatial functional hotspots
By using adjusted p values of Fisher's exact test < 0.05
after Bonferroni adjustment as the criteria, a total of 540
GO gene sets showed the functional enrichment in 838
SFHs. There are 443, 269, and 126 of SFHs belonging to
BP, MF, and CC terms, respectively. On average, each
chromosome contains 57 SFHs. Chromosome 1 has the
largest number (147) of SFHs, and chromosome Y has
no SFH (Figure 2A). The averaged SFH density is 0.43
SFHs per million base pairs (Mbp). Chromosome 6 has
the highest SFH density (0.48 SFHs/Mbp) (Figure 2B).
For the 838 SFHs, the average length of SFHs was 0.56
Mbp (Figure 2C) and the averaged 11.5 genes are in a
SFH (Figure 2D). The SFH of ‘sugar binding’ enrich-
ment, which is located in the 7.88 to 10.6 Mbp region at
chromosome 12, has the longest region length. The SFH
of ‘immune response’ enrichment (31.2 to 33 Mbp at
chromosome 6), which contains 93 genes, has the largest
number of genes. The region located in 29.7 to 31.5
Mbp at chromosome 6 contained the most number of
enriched gene sets (16) (Figure 2E and Additional file 1:
Table S1). The region includes lots of SFHs which have
enrichment of immune-related gene sets, such like MHC
class I protein complex, type I interferon-mediated signaling
pathway, and immune response. Our finding indicated that
the two regions are important for cell immunity.tion
t
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significant SFHs, which contain 18 functions, were showed in the
osomes 12 and 17. The ‘response to stimulus’ function was enriched at
Table 1 Top ten gain/loss spatial functional hotspots (SFHs) of HCC with enriched functions
Chr Start pos End pos Number of CNVs Presented gene set Number gene sets
Gain
1 153.33 153.59 59 bp Response to lipopolysaccharide 4
1 153.27 153.43 59 bp Innate immune response 4
1 153.33 153.36 59 bp Response to zinc ion 2
1 152.27 153.43 59 bp Epidermis development 13
1 152.27 153.23 59 mf Structural molecule activity 8
1 152.88 153.43 58 bp Keratinocyte differentiation 12
1 152.88 153.23 58 bp Peptide cross-linking 6
1 152.88 153.23 58 mf Protein binding, bridging 4
1 153.50 153.60 57 mf Protein homodimerization activity 5
1 153.50 153.60 57 cc Perinuclear region of cytoplasm 5
Loss
8 6.84 6.88 42 bp Response to virus 3
4 190.39 191.01 40 mf Sequence-specific DNA binding 6
4 190.39 191.01 40 mf Sequence-specific DNA binding transcription Factor activity 6
8 6.35 6.91 40 cc Extracellular space 7
4 90.80 91.76 40 cc Platelet alpha granule lumen 2
4 90.80 91.76 40 bp Platelet degranulation 2
8 26.61 27.47 39 bp Response to stress 3
17 10.35 10.56 38 bp Actin filament-based movement 2
8 26.37 27.31 37 bp Response to cocaine 2
8 22.88 23.08 37 mf Caspase activator activity 2
Immune-related functions are in italics.
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genomic positions were showed in Figure 2F. There are
nine SFHs which have adjusted p value smaller than 1 ×
10−20. The ‘intermediate filament’ gene set has the most
significant adjusted p value (7.4 × 10−50) of the enrichment
in the SFH of 38.8 to 39.4 Mbp region at chromosome 17.
Twenty-nine out of 57 genes in the ‘intermediate filament’
gene set are located at the hotspots. All of them belong to
the keratin family genes, which are components of the
cytoskeleton of epithelial cells. The top 20 SFHs were
showed in Figure 3. Another SFH which is located at 52.6
to 53.3 Mbp region at chromosome 12 also showed the
enrichment of intermediate filament. Other 12 keratin
genes were contained. The SFH located at 31.2 to 33
Mbp regions of chromosome 6, which code 16 human
leukocyte antigen (HLA) genes, enriched the immune
response gene set. In summary, our result indicates that
there are several functional hotspots within human
genome related to the immune function.
The affected function of copy number variation in liver
cancer
To evaluate the effect function of CNAs in liver cancer,
the dataset GSE14322, which contains 76 aCGH arraysof HCC samples, was downloaded and analyzed. The
percentage of CNA status of each SFH was calculated.
There are 61 and 89 SFHs that contained copy number
gain and loss in more than 30% patients (25). The result
was showed in Table S2 in Additional file 1, and the top
ten SFHs were listed in Table 1. One immune-related
gene set had the gain status in most of the samples
(innate immune response), and one had loss status
(response to virus), since the major etiologies of HCC
are the infection of HBV and HCV. We hypothesize that
those immune-related SFHs that harbor CNAs may play
a role in the HCC carcinogenesis.
We also analyzed the association between disease-free
survival and the CNAs of the SFHs through log rank
test. Using p < 0.01 as the threshold, a total of 20 and 19
SFHs of which gain and loss status were identified with
survival association, respectively (see Table 2). The copy
number gain status in the SFH which located at 41.1 to
41.9 Mbp at chromosome 19 had the smallest p value of
the survival testing. The SFH had the enrichment of
‘oxygen binding’. As shown in Figure 4A, the patients
with copy number gain in the SFH had reduced survival
comparing with neutral status. Interestingly, all the SFHs
with survival-associated gain status were all located at
Table 2 The SFHs of which copy number status were associated with patient survival
Chr Start pos End pos p value Presented gene set Number of overlapped genes
Gain
19 41.38 41.63 2.6E-04 mf Oxygen binding 2
19 43.23 44.29 0.001 bp Defense response 4
19 54.72 55.11 0.002 bp Defense response 6
19 54.72 55.11 0.002 bp Cell surface receptor linked Signaling pathway 6
19 40.09 40.23 0.003 mf Lysophospholipase activity 2
19 40.09 40.23 0.003 mf Carboxylesterase activity 2
19 39.41 39.52 0.004 cc SCF ubiquitin ligase complex 2
19 39.41 39.52 0.004 mf Glycoprotein binding 2
19 51.63 52.15 0.007 mf Sugar binding 9
19 54.78 55.38 0.007 bp Regulation of immune response 8
19 51.63 52.27 0.007 bp Cell adhesion 11
19 42.18 44.32 0.007 cc Anchored to membrane 9
19 54.72 55.55 0.007 mf Transmembrane receptor activity 8
19 54.80 55.30 0.007 mf Antigen binding 5
19 54.78 55.42 0.007 bp Cellular defense response 5
19 54.72 55.55 0.007 cc Integral to plasma membrane 12
19 58.55 59.08 0.007 bp Viral reproduction 7
19 54.78 55.40 0.007 bp Immune response 6
19 50.86 51.59 0.008 mf Peptidase activity 17
19 45.41 45.45 0.008 mf Lipid transporter activity 2
Loss
8 11.83 12.18 2.4E-04 bp Defense response to bacterium 4
4 55.10 55.99 0.001 bp Vascular endothelial growth Factor receptor signaling pathway 2
4 55.10 55.99 0.001 mf Growth factor binding 2
8 22.88 23.08 0.001 mf Caspase activator activity 2
8 22.30 23.02 0.002 bp Apoptosis 5
4 74.61 74.97 0.003 bp Inflammatory response 5
8 26.37 27.47 0.004 cc Growth cone 3
8 26.37 27.32 0.004 bp Response to cocaine 2
8 22.01 23.08 0.005 bp Cellular response to mechanical stimulus 3
4 68.69 69.36 0.006 mf Serine-type endopeptidase activity 5
4 68.69 69.36 0.006 bp Proteolysis 5
4 68.69 69.36 0.006 mf Peptidase activity 5
4 70.86 71.40 0.007 bp Biomineral tissue development 5
4 71.06 71.47 0.007 bp Odontogenesis of dentine-containing tooth 3
4 74.26 74.85 0.007 cc Platelet alpha granule lumen 3
4 74.26 74.85 0.007 bp Platelet degranulation 3
4 76.92 76.94 0.008 bp Defense response to virus 2
4 74.70 75.32 0.008 bp Cell-cell signaling 4
8 38.13 38.33 0.008 bp Cell growth 2
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immune-related functions, defense response, regulation of
immune response, antigen binding, and immune response,were enriched in the region. The finding indicated that
the immune functional island located at the region is sen-
sitive to patient survival. The SFH located at 11.8 to 12.2
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Figure 4 Patient survival correlated to copy number status of tumor. (A) Kaplan-Meier plots of patient disease-free survival were separated
by the status of copy number in the SFH located at 41.1 to 41.9 Mbp at chromosome 19. The SFH has enrichment of ‘oxygen binding’. Samples
were assigned to two groups, copy number gain (red line) and neutral (blue line). The p values was statistically significant (<0.01). (B) Kaplan-
Meier plots of the copy number status in SFH at 11.8 to 12.2 Mbp at chromosome 8. Samples were assigned to two groups, copy number loss
(green line) and neutral (blue line). The SFH had enrichment of ‘defense response to bacterium’. The p value of test was also significant.
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response to bacterium’, has the smallest p value of copy
number loss status (Figure 4B). For SFHs with survival-
associated loss status, 12 of them were located at 55 to
76.9 Mbp region at chromosome 4, and 7 of them were lo-
cated at 11.1 to 38.3 Mbp at chromosome 8.
Discussion
We introduced a system biology method, motivated by
Cancer Gene Island, to identify the spatial functional
hotspots in human genome. A statistical assay was pre-
sented to estimate the enrichment within genome re-
gions to functional gene sets. By applying the terms of
Gene Ontology into our method, the result provided the
details of the function encoded in human genome. We
set the two parameters of the algorithm, the length of
window size and shift distance, as 1 and 0.25 Mbp, re-
spectively. Although the setting of the parameters will
affect the p value of enrichment testing for each seg-
ment, our algorithm performed an optimal procedure
which merge the continual enriched segments and find
the region with maximum p values by removing the
gene one by one from both sides. Different settings of
window size will not affect the results of final optimal
regions. However, the detection of continual functional
enriched segments could be missed under the condition
of small window size because the windows contained no
and less genes. To find out the workable parameters, we
tested three conditions of window sizes, 0.5, 1, and 1.5
Mbp and found out that the condition of 0.5 Mbp con-
tains large numbers of segments of which the gene num-
ber is less than three. The parameters of 1 and 1.5 Mbpcontain fewer segments with low numbers of genes.
Through the testing, we set the window size as 1 Mbp
to analyze the human genome.
We applied the method in HCC data set to estimate
the effect of hotspots in the genome. Using the data set
GSE14322 as an example, a total of 150 SFHs have been
identified with copy number alterations in most of the
HCC patients, and the novelty of our analysis is to iden-
tify the functional hotspots in human genome. The re-
gion we identified is located with high density of genes
that share the same biological function, and as we dem-
onstrated in the HCC dataset, these functions may also
be sensitive to CNAs. Two immune-related functional
regions were identified with gain or loss in most of pa-
tients in the HCC dataset. The major carcinogenesis of
HCC is the chronic and acute inflammation under HBV
or HCV infection; thus, we hypothesize that these two
regions we identified may also play a role in HCC
oncogenesis.
We also identified 39 SFHs of which the copy number
status was associated with patient survival. The result in-
dicates that the copy number alterations in these regions
may affect the function of tumor progression and then
reflect on patient survival. For example, the patients
who have copy number loss in the SFH which was
enriched in inflammatory response have shorter survival.
The chronic and acute inflammations induced by HBV
and HCV infection have been proved to play an import-
ant role in HCC tumorgenesis [22,23]. Our data implied
that copy number alterations may contribute in the in-
flammatory response. Also, other enriched functions in
survival-related SFHs have been reported, such as
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and caspase activator activity. The SFHs and enriched
function we identified provided the clues of the associ-
ation between CNAs and the regulations of the enriched
functions. We expected that the SFHs we identified will
provide further insight of affected functions of CNAs to
uncover the mechanism of cancer.
Conclusions
In this paper, we systematically surveyed human genome
and identified 838 functional hotspots based on Gene
Ontology classification. To substantiate our findings, 76
HCC tumors and their DNA copy number gain/loss sta-
tuses were examined closely. Among the 838 hotspots, a
total of 150 regions affected by CNAs, and the encoded
enriched functions were identified. Our results indicate
that two immune-related hotspots had copy number al-
terations in most of the patients and might be involved
in HCC oncogenesis. In addition, 39 survival-related
hotspots were identified. Taken together, our results
demonstrated that the method presented in the paper is
a powerful tool to survey biological functions of CNAs
and to construct regulation hypothesis at pathway and
functional levels.
Additional file
Additional file 1: Supplemental materials. This file contains tables and
a figure showing the enriched functions, spatial functional hotspots, and
histogram of the gene numbers.
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